Andrew M Busch1,2, John Fani Srour3,4, James A Arrighi3,4, Christopher W Kahler5, Belinda Borrelli6,3. 1. The Miriam Hospital,Centers for Behavioral & Preventive Medicine, Coro West, Suite 309,164 Summit Ave, Providence, RI, 02906, USA. Andrew_busch@brown.edu. 2. Warren Alpert Medical School of Brown University, Providence, RI, USA. Andrew_busch@brown.edu. 3. Warren Alpert Medical School of Brown University, Providence, RI, USA. 4. Rhode Island Hospital, Providence, RI, USA. 5. Brown University School of Public Health, Providence, RI, USA. 6. The Miriam Hospital,Centers for Behavioral & Preventive Medicine, Coro West, Suite 309,164 Summit Ave, Providence, RI, 02906, USA.
Abstract
BACKGROUND: Continued engagement in valued life activities is a protective factor for depression and has been linked to readiness to quit smoking in medical populations but has never been examined among acute coronary syndrome (ACS) patients. PURPOSE: The purpose of this study is to investigate relationships among valued life activities, mood, and smoking post-ACS. METHODS: Participants were 54 post-ACS patients who were smoking before ACS hospitalization. Data on mood, smoking status, engagement in valued activities, restriction of valued activities, and satisfactory replacement of restricted activities was collected 1-12 months post-ACS. RESULTS: Depressive symptoms were associated with both less valued activity engagement and greater valued activity restriction. Positive affect was associated with greater valued activity engagement and negative affect was associated with greater valued activity restriction. Satisfactory replacement of restricted activities was associated with greater positive affect, fewer depressive symptoms, and quitting smoking post-ACS. The majority of these relationships remained significant after controlling for relevant covariates, including physical functioning. CONCLUSIONS: Valued activity restriction and engagement may contribute to depressed mood and failure to quit smoking in ACS patients. Psychotherapies that target greater engagement in valued life activities deserve further investigation in ACS patients.
BACKGROUND: Continued engagement in valued life activities is a protective factor for depression and has been linked to readiness to quit smoking in medical populations but has never been examined among acute coronary syndrome (ACS) patients. PURPOSE: The purpose of this study is to investigate relationships among valued life activities, mood, and smoking post-ACS. METHODS:Participants were 54 post-ACS patients who were smoking before ACS hospitalization. Data on mood, smoking status, engagement in valued activities, restriction of valued activities, and satisfactory replacement of restricted activities was collected 1-12 months post-ACS. RESULTS:Depressive symptoms were associated with both less valued activity engagement and greater valued activity restriction. Positive affect was associated with greater valued activity engagement and negative affect was associated with greater valued activity restriction. Satisfactory replacement of restricted activities was associated with greater positive affect, fewer depressive symptoms, and quitting smoking post-ACS. The majority of these relationships remained significant after controlling for relevant covariates, including physical functioning. CONCLUSIONS: Valued activity restriction and engagement may contribute to depressed mood and failure to quit smoking in ACS patients. Psychotherapies that target greater engagement in valued life activities deserve further investigation in ACS patients.
Authors: Brent T Mausbach; Elizabeth A Chattillion; Raeanne C Moore; Susan K Roepke; Colin A Depp; Scott Roesch Journal: Clin Psychol Rev Date: 2011-04-28
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol Journal: JAMA Date: 2003-08-20 Impact factor: 56.272
Authors: Anne N Thorndike; Susan Regan; Kathleen McKool; Richard C Pasternak; Susan Swartz; Nancy Torres-Finnerty; Nancy A Rigotti Journal: Arch Intern Med Date: 2008-01-28
Authors: Wendy Zhang; Nadia O'Brien; Jamie I Forrest; Kate A Salters; Thomas L Patterson; Julio S G Montaner; Robert S Hogg; Viviane D Lima Journal: PLoS One Date: 2012-07-19 Impact factor: 3.240
Authors: Andrew M Busch; Erin M Tooley; Shira Dunsiger; Elizabeth A Chattillion; John Fani Srour; Sherry L Pagoto; Christopher W Kahler; Belinda Borrelli Journal: BMC Public Health Date: 2017-04-17 Impact factor: 3.295
Authors: Emily C Gathright; Katherine Diaz Vickery; Woubeshet Ayenew; Matthew C Whited; Melissa Adkins-Hempel; Michelle Chrastek; Jill K Carter; Rochelle K Rosen; Wen-Chih Wu; Andrew M Busch Journal: PLoS One Date: 2022-02-03 Impact factor: 3.240